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There is uncertainty about the variation in infection prevention practices for central venous
catheters (CVC) in neonatal units (NNUs) and how practices relate to national guidance.
Aim
To evaluate evidence supporting infection prevention practices for CVCs recommended in
national guidelines and to compare with reported practices for peripherally inserted central
catheters (PICC), a type of CVC widely used in NNUs.
Design
We searched national guidelines for neonates and children to identify infection prevention
practices for CVCs and conducted an overview of studies to determine the quality of evi-
dence underpinning recommendations. We surveyed 134 NNUs in England and Wales to
ascertain reported practice.
Results
We found low quality evidence supporting CVC care bundles and use of 2% alcoholic
chlorhexidine to decontaminate catheter ports and skin before insertion. Moderate quality
evidence supported recommendations against routinely replacing CVCs and against chlor-
hexidine-impregnated dressings. 90% (44/49) of NICUs and 40% (34/85) of LNUs re-
sponded. 66% (48/73) of NNUs reported using CVC care bundles for insertion; 62% (45/73)
used bundles for maintenance. 63% (32/51) of those using bundles reported monitoring
adherence. 85% (61/72) of NNUs did not routinely replace PICCs and 89% (63/71) did not
use chlorhexidine-impregnated dressings. Antiseptic use varied with alcoholic 2% chlorhexi-
dine used for skin preparation in 33% (23/71) of NNUs and for catheter ports in 52% (37/71).
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Conclusions
Lack of consistency across NNUs in antiseptic use and low rates of reported CVC care bun-
dle use may reflect the low quality of evidence of the effectiveness and safety of these inter-
ventions in NNUs. Clinical trials are needed to quantify benefits and harms of infection
prevention practices in NNUs.
Introduction
Central venous catheters (CVCs) allow the administration of parenteral nutrition, fluids and
medication in neonatal units (NNUs). Peripherally inserted central catheters (PICCs) are a
type of CVC often used in NNUs because they can be inserted at the bedside and can remain
in situ for many days. However, CVCs increase the risk of bloodstream infection (BSI).[1, 2]
Neonatal BSI is associated with mortality, increased length of stay and long term morbidity.
[3–5] Pathogens colonising the skin enter the bloodstream during CVC insertion or through
migration along the catheter surface after insertion.[6–8] In addition, pathogens may be intro-
duced into the blood stream when the CVC connection is breached to administer medication
or fluids.[7, 9] Neonates have an elevated risk of BSI compared with older children and adults
due to their immunological immaturity, thinner and more permeable skin, exposure to fre-
quent invasive procedures and reliance on parenteral nutrition.[10–12]
In the UK, consensus guidelines for CVC care that reduce the risk of BSI are based mainly
on evidence in adults.[13] Guidelines are needed that specifically address CVC practices for
neonates as adverse effects can occur in neonates when using alcohol, chlorhexidine and
iodine based skin antiseptic solutions.[14–17] CVC replacement is difficult in neonates, guid-
ance is needed on how to minimise infection risk while maintaining the CVC in situ.[18]
In this study, we conducted an overview of national and international guidance, systematic
reviews, randomised controlled trials (RCTs) and observational studies to determine the
strength of evidence supporting infection prevention practices for CVCs in neonates. We also
surveyed NNUs in England and Wales to determine reported adoption of these practices. We
hypothesised that variation in adoption of PICC infection prevention practices would be great-
est for those practices with the lowest quality supporting evidence or where evidence is uncer-
tain or suggests the practice is potentially harmful for neonates.
Materials and methods
Evaluation of evidence and guidelines
Five CVC infection prevention practices relevant to NNU practice and likely to be measurable
by a short survey were selected from the EPIC3 UK guidelines by two neonatologists (SO, LD)
(Table 1).[13] We searched PubMed for systematic reviews of studies that evaluated CVC
related infection prevention practices in NNUs and PICUs, details of search are given in S1
appendix A. Although our focus was on NNUs, more than half of PICU admissions are aged
less than 12 months old and we expect practice for infants and neonates to be similar. We addi-
tionally searched for studies published since the latest review for each practice (S1 File). We
also included any other relevant studies by searching citations and related articles of included
studies. We used the GRADE approach to evaluate the evidence supporting each practice in
neonates.[19] GRADE is a system for rating quality of evidence and strength of recommenda-
tions that initially grades RCTs as high quality evidence and observational studies as low
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Table 1. Recommended practice, supporting evidence and quality and strength of evidence according to GRADE criteria.
Practice EPIC3 guideline recommendation Supporting evidence (summary of studies
in S1 File)
Quality and strength of evidence
using GRADE
1) Use of a care bundle for (a)
insertion or (b) maintenance of
PICCs and (c) monitoring
compliance of care bundles
Use quality improvement interventions
including protocols for catheter insertion
and maintenance, audit of compliance with
practice and feedback to practitioners.
Guidelines note that these are commonly
implemented as bundles.
A systematic review of CVC bundles in all
ages and three reviews of CVC bundles in
neonates or children found evidence of a
reduction in BSI associated with CVC
bundles, but the included studies were of
low quality.[24–27] The only RCT
identified evaluated a parenteral nutrition
care bundle in neonates and found no
difference in rates of late onset sepsis
between the bundle and standard care.[28]
We found six subsequent ‘before versus
after’ studies, all of which reported reduced
BSI rates after introduction of CVC
bundles.[29–34] Only one study (KH) took
into account pre-existing BSI trends and
adjusted for case mix.[32] This UK study
found a small but significant (14%)
reduction in BSI rate after introduction of
CVC bundles. CVC bundles were
consistently associated with a reduction in
BSI rates in before vs after studies.
Low quality of the evidence, weak
strength of recommendation
(observational studies, one RCT
found no difference)
2) Routine replacement or
removal of PICCs after a
specified time period
Do not routinely replace CVCs to prevent
infections.
We found no systematic reviews that
evaluated routine replacement of CVCs in
neonates or children. One systematic
review of 12 RCTs in adults concluded that
routine replacement of CVCs does not
reduce the rate of BSI compared with
replacement as needed.[35]
Moderate quality evidence, strong
strength of recommendation
(RCT evidence in adults is indirect)
3) Use of chlorhexidine-
impregnated foam dressing at
site of PICC insertion.
Do not use chlorhexidine-impregnated foam
dressing in neonates. Only use in adults.
A systematic review of RCTs evaluating the
efficacy and safety of antimicrobial
dressings in reducing BSI for neonates only
identified one small RCT evaluating
chlorhexidine-impregnated dressings.[36]
Chlorhexidine-impregnated dressings have
a moderate effect on catheter colonisation,
no significant effect on BSI and a high risk
of contact dermatitis.
Moderate quality evidence, strong
strength of recommendation
(RCT is small and subject to bias
but shows risk of harm with no
effect on BSI)
4) 2% chlorhexidine in alcohol
for skin preparation prior to
insertion of PICC.
Apply 2% chlorhexidine in alcohol at the
CVC insertion site.
Two reviews, conducted 10 years apart,
found no RCTs that showed a significant
benefit of chlorhexidine for skin preparatin
in neonates on rates of BSI.[37, 38] There
are concerns regarding the toxicity of
chlorhexidine and alcohol, particularly
neurotoxicity in the case of chlorhexidine.
[39–42]) A recent RCT in neonates found
10% providone-iodine and 2%
chloehexidine in alcohol to be equally
effective at reducing CLABSI with no
difference in skin damage, but the study
was underpowered.[43]
Low quality evidence, weak strength
of recommendation
(one underpowered RCT and
evidence of harm)
5) Cleaning of catheter ports with
2% chlorhexidine in alcohol.
Decontaminate CVC access ports with 2%
chlorhexidine in alcohol.
No studies met our inclusion criteria. One
before and after study in neonates that did
not report pre-existing trends found a
reduction in BSI when changing from 70%
isopropyl alcohol alone to 2% chlorhexidine
in 70% isopropyl alcohol to clean CVC
connectors.[44] The evidence in adults
cited in the epic3 guidelines should be
applicable to neonates as the mechanism for
colonisation is unlikely to differ in the two
age groups.[45, 46]
Low quality evidence, weak strength
of recommendation
(no RCTs in correct population)
https://doi.org/10.1371/journal.pone.0204894.t001
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quality evidence. Evidence is graded up or down based on study limitations, inconsistency of
results, indirectness of evidence, imprecision, reporting bias, and the magnitude of the treat-
ment effect.
Study population and survey design
We developed a short questionnaire about PICC care practices to be completed by neonatolo-
gists or senior neonatal nursing staff in NNUs in England and Wales (S2 File). Questions
about antiseptic agents in NNUs referred to typical practice for a 29 week gestation baby
weighing 900g and provided a list of antiseptics for respondents to choose from. Other ques-
tions gave the options yes, no or not applicable. Questions on cleaning of the CVC extension
set included photographs of relevant parts of the PICC. We encouraged respondents to answer
the survey in collaboration with colleagues so answers reflected agreed practice at the NNU.
After piloting the survey at four neonatal intensive care units (NICUs), the original survey
contained 23 questions. We distributed the survey to a consultant contact at each of 134
NNUs: 49 NICUs which provide care for the most unwell or unstable babies and 85 local neo-
natal units (LNUs) which provide high dependency care to babies who require highly skilled
staff but require a lower staff to patient ratios.[20] Special care baby units (SCBUs) for babies
who require neonatal care other than intensive or high dependency care were not included in
the study as PICCs are not usually used in these units. Contacts were identified from the
National Neonatal Audit Programme contact list for all neonatal units in the UK.[21] The sur-
vey was first distributed in December 2015 using the online survey platform SurveyMonkey
with the option to print the survey and return by post or email. Between December 2015 and
May 2016, we sent five follow up emails containing the original online survey to the consultant
contacts and advanced neonatal nurse practitioners identified from the Neonatal Nurses Asso-
ciation contact list.
To improve the response rate, we condensed the survey into a printable 2-page document
containing 10 questions, prioritising questions judged clinically important, previously well
completed, describing measurable practices or covered by existing systematic reviews. In May
2016 we re-sent the survey to NNUs that had not yet provided a complete response. In June
2016, we sent a personalised final email reminder to complete the condensed survey non-
responding NICUs, which was addressed to a consultant known at the unit by the clinical
investigator for the study (SO). NICUs were prioritised as they use PICCs most frequently.
Analysis
We counted responses from NNUs with no questions answered as non-respondents, but
responses that answered at least one question were included. Where we received multiple
responses from the same NNU, we included answers from the first responding consultant in
the main analysis. An additional duplicate analysis compared multiple responses from the
same NNU to assess consistency of answers. We classified multiple responses as in agreement
if more than one professional from a NNU provided the same answer.
Ethics
This study did not require Research Ethics Approval as we asked staff about their usual
practice.[22] Informed consent for completion of the survey was obtained by virtue of comple-
tion and return of the survey in accordance with Health Research Authority guidance.[23]
Additional consent to acknowledge participants by name was gained by participants ticking a
box.
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Results
Guidelines and evidence
The practices selected for our study were: use of CVC care bundles for insertion and mainte-
nance, monitoring of bundle compliance, use of chlorhexidine impregnated dressing, routine
removal or replacement of CVCs, and use of 2% chlorhexidine in alcohol for skin preparation
and port disinfection.
We found low quality evidence supporting the use of care bundles, and cleaning catheter
ports with 2% chlorhexidine in alcohol and moderate quality evidence to support recommen-
dations to avoid use of chlorhexidine impregnated foam dressings and to avoid routine
replacement of CVCs (Table 1). The remaining practices were only supported by low quality
evidence. We have combined evidence for use of, and audit and compliance to bundles
because most bundles studied include a measure of compliance and we did not identify any
studies that assess the efficacy of measuring compliance independently from use of a bundle.
Responses
We obtained at least one response to the original survey from 28% (24/85) of LNUs and 55%
(27/49) of NICUs in England and Wales (S1 Fig). Initially, responses were returned from 23%
(5/22) of NICUs that received the condensed questionnaire, but following personalised e-mails
to non-responding NICUs the response rate increased to 77% (17/22). Overall 58% (78/135) of
NNUs provided at least one response, from 90% (44/49) NICUs and 40% (34/85) LNUs. The
condensed, two-page questionnaire (15 responses) was mostly completed on screen (12) with
3 respondents returning a printed survey. Full responses are provided in S3 File.
Duplicate analysis
Forty eight responses from 21 units were analysed in the duplicate analysis. Duplicate respon-
dents from the same NNU gave consistent answers for questions concerning use of bundles,
monitoring compliance of bundles and routine replacement or removal of PICCs (Table 2).
However, duplicate respondents often gave divergent responses to questions about antiseptic
agents for skin preparation and catheter port cleaning.
Reported practice
Two thirds of NNUs reported using care bundles for PICC insertion and maintenance
(Table 3). There were five NNUs that reported using only one type of bundle. The majority of
Table 2. Comparison of reported practices from NNUs that provided duplicate responses.
Practice NNUs that provided the same answer in duplicate responses�
1a) Use a care bundle for PICC insertion 14/14 (100%)
1b) Use a care bundle for PICC maintenance 12/14 (86%)
1c) Monitor and feedback bundle compliance 12/14 (86%)
2) No routine removal or replacement of PICCs 13/15 (87%)
3) Avoid CHX-impregnated foam dressing 9/14 (64%)
4) Use 2% CHX in alcohol as skin preparation 6/13 (46%)
5) Clean catheter ports with 2% CHX in alcohol 7/14 (50%)
�21 NNUs had more than one response to at least one question. We show the number of NNUs with more than one
response for each question. CHX = chlorhexidine
https://doi.org/10.1371/journal.pone.0204894.t002
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NNUs reported that PICC replacement was not routine and did not use chlorhexidine impreg-
nated foam dressings. Of the 11 NNUs that reported routine removal or replacement, ten gave
the time at which they would remove or replace the catheter and the remaining NNU was in
process of devising a protocol. The median number of days to removal or replacement was 14
(range 7 to 42). Four of those that reported routine removal or replacement commented that
the limit could be extended if necessary.
All NNUs reported using a form of chlorhexidine for skin disinfection prior to insertion
but the concentration and use of alcohol vs aqueous solutions varied with one-third using 2%
chlorhexidine in alcohol (Fig 1). Ten respondents reported a two-step technique for skin anti-
sepsis prior to PICC insertion, for example applying 1% aqueous chlorhexidine initially and
performing a second clean with 2% chlorhexidine in alcohol.
2% chlorhexidine in alcohol was the most commonly used antiseptic for cleaning catheter
ports, followed by 70% isopropyl alcohol (Fig 2). Nine respondents reported having a two-step
process for catheter port cleaning.
There was no difference in use of 2% chlorhexidine in alcohol to clean catheter ports
between NNUs that use bundles and those that did not, but use of 2% chlorhexidine in alcohol
as skin preparation was more common in bundle users than non-users (Table 4).
Discussion
We found variation in adherence to recommended care practices, and a lack of high quality
evidence supporting these in neonates. Reported practice from the majority of NNUs was in
accordance with recommendations against routine replacement of PICCs and against use of
chlorhexidine-impregnated foam dressing, supported by moderate quality evidence. Despite
only low quality evidence to support the use of care bundles in neonates, the majority of
NNUs reported using insertion and maintenance bundles.
A strength of the study was the response rate of 88% for NICUs. The lower response rate
from LNUs may reflect fewer PICC insertions in LNUs or a higher level research engagement
among NICU practitioners. The high response rate from NICUs was achieved after reducing
the questionnaire length and repeated personal reminders. Other studies have highlighted the
importance of personal contact.[47] A limitation of the study is that we analysed reported
practice, rather than actual practice. The duplicate analysis demonstrates the validity for the
questions on use of care bundles and routine removal or replacement of PICCs. However, the
inconsistencies for chlorhexidine dressing and antiseptic use suggest there is uncertainty
regarding these topics. It is unclear whether the uncertainty is related to the survey design, for
Table 3. Reported practice stratified by unit level.







1a) Use a care bundle for PICC insertion 66% (48/73) 72% (31/43) 57% (17/30)
1b) Use a care bundle for PICC maintenance 62% (45/73) 65% (28/43) 57% (17/30)
1c) Monitor and feedback bundle compliance 63% (32/51) 66% (21/32) 58% (11/19)
2) No routine removal or replacement of PICCs 85% (61/72) 79% (34/43) 93% (27/29)
3) Avoid CHX-impregnated foam dressing 89% (63/71) 93% (39/42) 83% (24/29)
4) Use 2% CHX in alcohol as skin preparation� 33% (23/71) 41% (17/42) 21% (6/29)
5) Clean catheter ports with 2% CHX in alcohol 52% (37/71) 55% (23/42) 48% (14/29)
NICUs = neonatal intensive care units, LNU = high dependency care unit, CHX = chlorhexidine �For a 29 week gestation baby weighing 900g
https://doi.org/10.1371/journal.pone.0204894.t003
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example respondents misunderstanding the question or accidentally selecting the wrong
answer, or due to real differences in practice within units.
Variation in chlorhexidine solutions may reflect differing interpretations of case studies
that report burns for aqueous and alcoholic chlorhexidine in very preterm babies.[15, 16, 39,
41, 42, 48, 49] Many before and after studies have reported statistically significant reductions
in BSI rates following adoption of care bundles.[27] The volume and consistency of these stud-
ies is likely to impact practice and opinion despite their low quality and risk of bias, and is a
potential reason for the greater adoption of these practices in contrast to use of 2% chlorhexi-
dine in alcohol. Variation in antiseptic solution used to clean skin before CVC insertion has
been reported elsewhere. Surveys of UK NICUs found 2% chlorhexidine in alcohol used in no
units in 2008 but in 39% (22/57) of units in 2013.[50, 51] This suggests the use of 2% chlorhexi-
dine in alcohol is a recent development in NNUs, which may follow the Matching Michigan
initiative.[52]
Use of 2% chlorhexidine in alcohol was more common in NNUs that used care bundles
than those that did not. This practice is included in the Department of Health Saving Lives
care bundle and the NHS England Matching Michigan programme, both of which were evi-
dence based interventions to reduce BSI rates in adult and paediatric intensive care.[52, 53]
Fig 1. Antiseptics that were reported for skin preparation prior to CVC insertion. NICUs = neonatal intensive care units, LNUs = high
dependency care units; CHX = chlorhexidine; units could select multiple choices therefore the sum of the percentages may be greater than 100.
https://doi.org/10.1371/journal.pone.0204894.g001
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There have been no equivalent national initiatives for neonatal intensive care. This suggests
some NNUs use bundles for adults and older children. There was less consistency between
units for use of care bundles and antiseptics compared to avoidance of routine replacement of
CVCs and chlorhexidine dressing. Factors influencing adoption of practices will include the
underlying evidence base, but also the experience of clinicians, organisational drivers such as
the UK’s Matching Michigan Programme and perceptions as to whether practices have likely
harms associated with them.
Practices with small effect sizes may have a greater value to neonates compared to other
populations due to the higher rate of BSI in NNU, therefore all practices would benefit from
Fig 2. Reported antiseptic use for disinfection of catheter ports. NICUs = neonatal intensive care units, LNUs = high dependency care units;
CHX = chlorhexidine; units could select multiple choices therefore the sum of the percentages may be greater than 100.
https://doi.org/10.1371/journal.pone.0204894.g002






4) Use 2% CHX in alcohol as skin preparation 19 (40%) 4 (19%)
5) Clean catheter ports with 2% CHX in alcohol 25 (52%) 11 (52%)
CHX = chlorhexidine
https://doi.org/10.1371/journal.pone.0204894.t004
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neonate specific evidence.[54, 55] Antiseptics have the most urgent need to be studied in neo-
nates due to the increased risk of adverse events. Without high quality evidence, there may be
a role for guidelines on a small scale to harmonise local practice and facilitate audit and quality
improvement. However, use of guidelines that are based on insufficient evidence on a large
scale, without due consideration of the quality of underpinning evidence, runs the risk of
encouraging clinicians to carry out practices that are either without value, or even harmful.
Further research is needed to determine the effectiveness and safety of CVC care practices
for reducing BSI in neonates. A multicentre UK RCT evaluating antimicrobial impregnated
versus standard PICCs for preventing BSI in preterm neonates is in progress (www.prevail.
org.uk). Our findings of inconsistent practice underline the need for adequately powered
RCTs to determine the effectiveness and safety of skin antiseptic agents.
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